Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 457 of 1,261

  1. US 10493149

    Stable anti-OSMR antibody formulation

    Kiniksa Pharmaceuticals, GmbH · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  2. US 10493151

    Etanercept formulations stabilized with sodium chloride

    Coherus BioSciences, Inc. · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  3. US 10493162

    Somatostatin receptor-based cancer therapy

    The Board of Regents of the University of Texas System · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  4. US 10494632

    Insulin-like growth factor binding protein, acid labile subunit (IGFALS) compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  5. US 10492477

    Humanized C5 animals

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  6. US 10494316

    Process for the preparation of deuterated ethanol from D2O

    Deuteria Beverages, LLC · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  7. US 10494683

    Nitrate- and nitrite-reducing probiotic feed additive

    The United States of America, as represented by the Secretary of Agriculture · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  8. US 10494444

    Anti-CD38 antibodies

    Takeda Pharmaceutical Company Limited · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  9. US 10495650

    Method for differentially diagnosing ACTH-dependent Cushing's syndrome

    Corcept Therapeutics Incorporated · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  10. US 10493057

    Acetogenin molecules having antiplatelet and/or antithrombic activities, and methods and compositions thereof

    INSTITUTO TECNOLÓGICO Y DE ESTUDIOS SUPERIORES DE MONTERREY · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  11. US 10493037

    Multiphasic particles fabricated by wettability engendered templated self-assembly (WETS) methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  12. US 10493030

    Combination HIV therapeutic

    Aphios Corporation · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  13. US 10494648

    Delivery methods and compositions for nuclease-mediated genome engineering

    Sangamo Therapeutics, Inc. · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  14. US 10494382

    Crystalline solvate comprising 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile, methanol, N-N-dimethylformamide, and water

    Theravance Biopharma R&D IP, LLC · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  15. US 10493077

    Fused imidazo-piperidine JAK inhibitor compound

    Theravance Biopharma R&D IP, LLC · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  16. US 10493087

    Sialylation-increasing therapies for diseases associated with oxidative stress

    The United States of America, as represented by National Institute of Health · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  17. US 10494442

    Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  18. US 10494435

    Human monoclonal antibodies specific for CD22

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  19. US 10494612

    Adeno-associated virus virions with variant capsid and methods of use thereof

    The Regents of the University of California · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  20. US 10494364

    Cathepsin K inhibitors and application thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  21. US 10493038

    Formulation of acoustically activatable particles having low vaporization energy and methods for using same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  22. US 10494327

    Controlled release pharmaceutical formulations

    United Therapeutics Corporation · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  23. US 10493253

    Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  24. US 10493081

    Methods for treatment of diseases

    Galera Labs, LLC · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.